This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alexander R. Stevens, Jr., MD

Arch Intern Med. 1970;125(5):883-884.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sickle cell anemia is a severe hemolytic disease caused by a congenital hemoglobin defect for which there is no treatment. Clinical management of patients with the disorder is purely symptomatic, and a "hands off" policy regarding transfusion is best. It is unusual to be able to offer any definitive treatment which holds promise for permanent improvement. Although rarely indicated, splenectomy can afford lasting benefit in the properly selected individual. Two such patients are reported.

Patient Summaries

PATIENT 1.

—This Negro man was seen many times between the ages of 5 and 12 years at King County Hospital, Seattle, for complications of sickle cell anemia. Hemoglobin levels were between 4.0 and 7.6 gm/100 ml. Reticulocytes ranged up to 14%. Sickling preparations gave positive reactions and hemoglobin electrophoresis showed a single S band. The spleen was reported as descending to the umbilicus when he was 5 years old and was below this . . . [Full Text PDF of this Article]

Author Affiliations
Seattle

From King County Hospital and the Swedish Hospital, Seattle.

Footnotes
Received for publication Sept 23, 1969; accepted Jan 9, 1970.

Read before the North Pacific Society of Internal Medicine, Spokane, Wash, April, 1968.

Reprint requests to 515 Minor Ave, Seattle 98104.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?